News room(en)

Interview with the Chairman of Jowin – Q&A

AI Precision Medicine Meets Traditional Cancer Treatment: JOWIN and ImpriMed Sign Joint Research Agreement

Jowin, which has shown great results in clinical trials of many stage 4 and terminal cancer patients in Korea over the past few years, sets this year as its first year of entering the global cancer care market and will establish a global telemedicine platform that provides high-quality non-face-to-face care services to patients with stage 4 and terminal cancer

Jowin plans to establish a telemedicine platform for overseas patients with stage 4 and terminal cancer and launch it in the first half of this year